Some showed elevated expression in NAFLD patients compared to non‐NAFLD controls, including ATP7B, SLC31A1, LIAS, DLD, PDHA1, PDHB and DBT. The gene discussed is LIAS; the disease is metabolic dysfunction-associated steatotic liver disease.